Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT02125461

Public ClinicalTrials.gov record NCT02125461. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 3:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomised, Double-blind, Placebo-controlled, Multi-centre, International Study of MEDI4736 as Sequential Therapy in Patients With Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Definitive, Platinum-based, Concurrent Chemoradiation Therapy (PACIFIC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Global Study to Assess the Effects of MEDI4736 following concurrent chemoradiation in Patients with Stage III Unresectable Non-Small Cell Lung Cancer.

Study identification

NCT ID
NCT02125461
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
713 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 7, 2014 (Actual)
Primary completion
Feb 13, 2017 (Actual)
Completion
Aug 24, 2023 (Actual)
Last update posted
Oct 10, 2023

2014 – 2023

United States locations

U.S. sites
60
U.S. states
26
U.S. cities
56
Facility City State ZIP Site status
Research Site Chandler Arizona 85224 —
Research Site Goodyear Arizona 85338 —
Research Site Jonesboro Arkansas 72405 —
Research Site Springdale Arkansas 72762 —
Research Site Fullerton California 92835 —
Research Site Los Angeles California 90095 —
Research Site Oxnard California 93030 —
Research Site Sacramento California 95816 —
Research Site San Diego California 92123 —
Research Site Santa Rosa California 95403 —
Research Site Norwich Connecticut 06360 —
Research Site Washington D.C. District of Columbia 20007 —
Research Site Fort Myers Florida 33901 —
Research Site Jacksonville Florida 32207 —
Research Site Miami Beach Florida 33140 —
Research Site Orlando Florida 32804 —
Research Site Port Saint Lucie Florida 34952 —
Research Site St. Petersburg Florida 33705 —
Research Site Tampa Florida 33612 —
Research Site Atlanta Georgia 30318 —
Research Site Atlanta Georgia 30322 —
Research Site Fort Gordon Georgia 30905 —
Research Site Lawrenceville Georgia 30046 —
Research Site Marietta Georgia 30060 —
Research Site Waterloo Iowa 50701 —
Research Site Topeka Kansas 66606 —
Research Site Hazard Kentucky 41701 —
Research Site Baltimore Maryland 21287 —
Research Site Rockville Maryland 20850 —
Research Site Rosedale Maryland 21237 —
Research Site Salisbury Maryland 21801 —
Research Site Towson Maryland 21204 —
Research Site Boston Massachusetts 02215 —
Research Site Lansing Michigan 48910 —
Research Site Minneapolis Minnesota 55426 —
Research Site St Louis Missouri 63110 —
Research Site Lincoln Nebraska 68510 —
Research Site Hackensack New Jersey 07601 —
Research Site Lake Success New York 11041 —
Research Site The Bronx New York 10461 —
Research Site Burlington North Carolina 27215 —
Research Site Charlotte North Carolina 28204 —
Research Site Pinehurst North Carolina 28374 —
Research Site Winston-Salem North Carolina 27103 —
Research Site Blue Ash Ohio 45242 —
Research Site Easley South Carolina 29640 —
Research Site Chattanooga Tennessee 37404 —
Research Site Nashville Tennessee 37203 —
Research Site Nashville Tennessee 37232-8805 —
Research Site Austin Texas 78731 —
Research Site Dallas Texas 75231 —
Research Site Dallas Texas 75246 —
Research Site Fort Worth Texas 76104 —
Research Site Houston Texas 77030 —
Research Site Tyler Texas 75702 —
Research Site Salt Lake City Utah 84106 —
Research Site Fairfax Virginia 22031 —
Research Site Spokane Washington 99208 —
Research Site Spokane Washington 99218 —
Research Site Vancouver Washington 98684 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 176 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02125461, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 10, 2023 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02125461 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →